Literature DB >> 11820705

Vascular plasticity--the role of the angiopoietins in modulating ocular angiogenesis.

A M Joussen1.   

Abstract

Most of the blinding diseases, such as diabetic retinopathy, age-related macular degeneration, neovascular glaucoma or trachoma, are related to an aberrant angiogenic response. Common pathological features are ischaemia and increased vascular permeability, in turn leading to neovascularization or atrophy. Recent effort has led to the identification of several factors, such as the angiopoietin-Tie system, which are operative in the control of vasculogenesis and angiogenesis. The aim of this commentary is to summarize briefly the current knowledge about molecular mechanisms involved in the regulation of vascular integrity with special emphasis on the angiopoietins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11820705     DOI: 10.1007/s004170100365

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium.

Authors:  Gottfried Martin; Günther Schlunck; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-14       Impact factor: 3.117

2.  The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.

Authors:  Graciela Krikun; Zhiwei Hu; Kevin Osteen; Kaylon L Bruner-Tran; Frederick Schatz; Hugh S Taylor; Paolo Toti; Felice Arcuri; William Konigsberg; Alan Garen; Carmen J Booth; Charles J Lockwood
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

3.  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.

Authors:  Kinga G Blecharz; Dietmar Frey; Tobias Schenkel; Vincent Prinz; Gloria Bedini; Susanne M Krug; Marcus Czabanka; Josephin Wagner; Michael Fromm; Anna Bersano; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 4.  Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential.

Authors:  Michael Whitehead; Andrew Osborne; Peter S Widdowson; Patrick Yu-Wai-Man; Keith R Martin
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

5.  A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.

Authors:  Markus Thomas; Yvonne Kienast; Werner Scheuer; Monika Bähner; Klaus Kaluza; Christian Gassner; Frank Herting; Ulrich Brinkmann; Stefan Seeber; Anita Kavlie; Martin Welschof; Stefan Ries; K Michael Weidner; Jörg T Regula; Christian Klein
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.